Working… Menu

Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00335348
Recruitment Status : Completed
First Posted : June 9, 2006
Last Update Posted : January 9, 2013
Janssen-Cilag Ltd.
Information provided by (Responsible Party):
Peter MacCallum Cancer Centre, Australia